06 Dec 2018
Posted by Andrew Kantor
CVS Health said it’s Caremark PBM will switch to a new pricing model: “Under new model, 100 percent of rebates are passed through to plan sponsors while PBM takes accountability for impact of drug price inflation and shifts in drug mix.”
Then again, it also said it’s completed its acquisition of Aetna, which isn’t true.
The Columbus Dispatch has a piece about the merger — specifically, the “one-of-a-kind” concessions we in Georgia got from CVS before the insurance commissioner would approve it.
Mylan is recalling every lot of its valsartan blood pressure medicine because of potential contamination.
The finished products, which were manufactured by Mylan Pharmaceuticals and Mylan Laboratories were distributed in the United States between March 2017 and November 2018.
The incomparable Jennifer Shannon — GPhA member and owner of Lily’s Pharmacy in Johns Creek — might be getting more than her 15 minutes of fame: Now she’s got an article published in the latest issue of NCPA’s America’s Pharmacist magazine, “Independent pharmacies: Sewing community health care together.”
Three of four nursing homes in the state have to pay penalties because too many of their patients end up readmitted to the hospital. Georgia Health News reports.
A bill introduced in the Senate would make it illegal for drugmakers to misclassify brand-name drugs as generics in order to trick Medicare into paying more. (With generics, they have to give Medicare plans a smaller rebate.) In other words, this wasn’t already illegal.
This is a scary thought: “Women who were victims of domestic violence were more than twice as likely to have a medical consultation for emergency contraception, British researchers found.”
The government says so, so it must be true.
No, it’s not a teaser for Avengers 4.